395 related articles for article (PubMed ID: 23939952)
41. A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis.
Li N; Feng L; Han HQ; Yuan J; Qi XK; Lian YF; Kuang BH; Zhang YC; Deng CC; Zhang HJ; Yao YY; Xu M; He GP; Zhao BC; Gao L; Feng QS; Chen LZ; Yang L; Yang D; Zeng YX
Cancer Lett; 2016 Oct; 381(1):14-22. PubMed ID: 27424523
[TBL] [Abstract][Full Text] [Related]
42. Increased phosphorylation of histone H3 at serine 10 is involved in Epstein-Barr virus latent membrane protein-1-induced carcinogenesis of nasopharyngeal carcinoma.
Li B; Huang G; Zhang X; Li R; Wang J; Dong Z; He Z
BMC Cancer; 2013 Mar; 13():124. PubMed ID: 23496845
[TBL] [Abstract][Full Text] [Related]
43. EBV-encoded LMP1 increases nuclear β-catenin accumulation and its transcriptional activity in nasopharyngeal carcinoma.
You S; Zhang F; Meng F; Li H; Liu Q; Liang Y; Dong Y; Yang W; Han A
Tumour Biol; 2011 Aug; 32(4):623-30. PubMed ID: 21336584
[TBL] [Abstract][Full Text] [Related]
44. Epstein-Barr virus oncoprotein LMP1 mediates survivin upregulation by p53 contributing to G1/S cell cycle progression in nasopharyngeal carcinoma.
Guo L; Tang M; Yang L; Xiao L; Bode AM; Li L; Dong Z; Cao Y
Int J Mol Med; 2012 Apr; 29(4):574-80. PubMed ID: 22266808
[TBL] [Abstract][Full Text] [Related]
45. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
[TBL] [Abstract][Full Text] [Related]
46. A human Fab-based immunoconjugate specific for the LMP1 extracellular domain inhibits nasopharyngeal carcinoma growth in vitro and in vivo.
Chen R; Zhang D; Mao Y; Zhu J; Ming H; Wen J; Ma J; Cao Q; Lin H; Tang Q; Liang J; Feng Z
Mol Cancer Ther; 2012 Mar; 11(3):594-603. PubMed ID: 22169768
[TBL] [Abstract][Full Text] [Related]
47. EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model.
Ke X; Yang YC; Hong SL
Med Oncol; 2011 Dec; 28 Suppl 1():S326-32. PubMed ID: 20862567
[TBL] [Abstract][Full Text] [Related]
48. LMP1 stimulates the transcription of eIF4E to promote the proliferation, migration and invasion of human nasopharyngeal carcinoma.
Zhao Y; Pang TY; Wang Y; Wang S; Kang HX; Ding WB; Yong WW; Bie YH; Cheng XG; Zeng C; Yao YH; Li Q; Hu XR
FEBS J; 2014 Jul; 281(13):3004-18. PubMed ID: 24814906
[TBL] [Abstract][Full Text] [Related]
49. [Epigallocatechin-3-gallate interferes with EBV-encoding AP-1 signal transduction pathway].
Zhao Y; Wang H; Zhao XR; Luo FJ; Tang M; Cao Y
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):393-7. PubMed ID: 15355641
[TBL] [Abstract][Full Text] [Related]
50. Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells.
Ma L; Deng X; Wu M; Zhang G; Huang J
FEBS Lett; 2014 May; 588(9):1562-70. PubMed ID: 24613926
[TBL] [Abstract][Full Text] [Related]
51. Modulation of LMP1 protein expression by EBV-encoded microRNAs.
Lo AK; To KF; Lo KW; Lung RW; Hui JW; Liao G; Hayward SD
Proc Natl Acad Sci U S A; 2007 Oct; 104(41):16164-9. PubMed ID: 17911266
[TBL] [Abstract][Full Text] [Related]
52. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
[TBL] [Abstract][Full Text] [Related]
53. Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy.
Xiao L; Hu ZY; Dong X; Tan Z; Li W; Tang M; Chen L; Yang L; Tao Y; Jiang Y; Li J; Yi B; Li B; Fan S; You S; Deng X; Hu F; Feng L; Bode AM; Dong Z; Sun LQ; Cao Y
Oncogene; 2014 Sep; 33(37):4568-78. PubMed ID: 24662831
[TBL] [Abstract][Full Text] [Related]
54. Anoikis resistance and immune escape mediated by Epstein-Barr virus-encoded latent membrane protein 1-induced stabilization of PGC-1α promotes invasion and metastasis of nasopharyngeal carcinoma.
Liao C; Li M; Chen X; Tang C; Quan J; Bode AM; Cao Y; Luo X
J Exp Clin Cancer Res; 2023 Oct; 42(1):261. PubMed ID: 37803433
[TBL] [Abstract][Full Text] [Related]
55. Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma.
Chen J; Hu CF; Hou JH; Shao Q; Yan LX; Zhu XF; Zeng YX; Shao JY
J Transl Med; 2010 Mar; 8():30. PubMed ID: 20338061
[TBL] [Abstract][Full Text] [Related]
56. TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition.
Liu SL; Lin HX; Lin CY; Sun XQ; Ye LP; Qiu F; Wen W; Hua X; Wu XQ; Li J; Song LB; Guo L
Cancer Lett; 2017 Aug; 402():117-130. PubMed ID: 28583847
[TBL] [Abstract][Full Text] [Related]
57. EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma.
Lu J; Tang M; Li H; Xu Z; Weng X; Li J; Yu X; Zhao L; Liu H; Hu Y; Tan Z; Yang L; Zhong M; Zhou J; Fan J; Bode AM; Yi W; Gao J; Sun L; Cao Y
Cancer Lett; 2016 Sep; 380(1):191-200. PubMed ID: 27255972
[TBL] [Abstract][Full Text] [Related]
58. Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma.
Kondo S; Wakisaka N; Schell MJ; Horikawa T; Sheen TS; Sato H; Furukawa M; Pagano JS; Yoshizaki T
Int J Cancer; 2005 Jun; 115(3):368-76. PubMed ID: 15688379
[TBL] [Abstract][Full Text] [Related]
59. EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy.
Fang W; Zhang J; Hong S; Zhan J; Chen N; Qin T; Tang Y; Zhang Y; Kang S; Zhou T; Wu X; Liang W; Hu Z; Ma Y; Zhao Y; Tian Y; Yang Y; Xue C; Yan Y; Hou X; Huang P; Huang Y; Zhao H; Zhang L
Oncotarget; 2014 Dec; 5(23):12189-202. PubMed ID: 25361008
[TBL] [Abstract][Full Text] [Related]
60. Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein Barr virus encoded latent membrane protein 1.
Song X; Tao Y; Tan Y; Lee LM; Deng X; Wu Q; Cao Y
Sci China C Life Sci; 2005 Feb; 48(1):70-80. PubMed ID: 15844359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
